The Galien Foundation
medal
Join us

Prix Galien Japan Awards Categories

dropdown-iconBest Pharmaceutical Product

dropdown-iconBest Biotechnology Product

dropdown-iconBest Product for Rare/Orphan Diseases

dropdown-iconBest Medical Technology

dropdown-iconBest Digital Health Solution

dropdown-iconBest Startup (Biotech & Medtech/Digital Health)

For Reference — 2025 Prix Galien USA Award Winners

Nobel Laureates’ Official Messages of Support for the Establishment of Prix Galien Japan

Shinya_Yamanaka_450

“Through international collaboration, innovation in medicine advances hope and transforms lives worldwide. The launch of the Prix Galien Japan embodies this spirit.”
- Prof. Shinya Yamanaka, Nobel Laureate - 2026

Tasuku_Honio_450

“My heartfelt congratulations on the launch of the Prix Galien in Japan. This award recognizes that the cumulative efforts of long-term research generate value for society and carry forward the progress and integrity of science into the future.”
- Prof. Tasuku Honjo, Nobel Laureate - 2026

Japan is an extraordinary contributor to life sciences research globally, preceeded only by the United States and China, and second only to the United States in branded medicines. Japan’s deeply scientific innovation agenda is focused on some of the most consequential frontiers in global health, from oncology and regenerative medicine to AI-enabled drug discovery, digital health, and advanced therapeutic platforms. With a culture celebrating precision, and the relentless pursuit of progress, its mature industrial fabric and scale backed by a national strategy to build a ¥100 trillion bioeconomy by 2030, Japan is the country to watch for biopharmaceutical innovation.

Prix Galien Japan Awards Committee

A prestigious committee comprising some of the finest distinguished researchers in their fields will be chaired by Professor Takashi Kadowaki, President of the Japanese Association of Medical Sciences. The committee will judge submissions to the inaugural prize in the categories: Best Pharmaceutical Product, Best Biotechnology Product, Best Orphan and Rare Disease Product, Best Medical Technology, Best Digital Health Solution, and Best Startup.

Takashi Kadowaki

Awards Subcommittee 

This subcommittee pre-screens all applications in the Best Pharmaceutical Product, Best Biotechnology Product, and Best Product for Rare/Orphan Diseases categories before submitting the shortlists.

Shizuo Akira
Shizuo Akira, MD, PhD
Center Director, Center for Advanced Modalities and Drug Delivery System, The University of Osaka
Yoshitsugu Aoki
Yoshitsugu Aoki, MD, PhD
Director, Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry
Toshihiko Doi
Toshihiko Doi, MD, PhD
Director, National Cancer Center Hospital East
Hideyuki Okano
Hideyuki Okano, MD, PhD
Distinguished Professor, Keio University; Director, Keio University Regenerative Medicine Research Center
Noriko Osumi
Noriko Osumi, PhD
Executive Director, Japan Society for the Promotion of Science; Professor Emeritus / Visiting Professor, Tohoku University
Tomoki Todo
Tomoki Todo, MD, PhD
Emeritus Professor, The Institute of Medical Science, The University of Tokyo
What they said
Ban-Ki-moon
“The Prix Galien is the right event, on the right issue at the right time. I thank the Galien Foundation for bringing us together and for recognizing that a healthier world is a safer world and a more just world.”
- Ban Ki-moon, UN Secretary-General - 2010
barrack-obama
“The Prix Galien is a welcome initiative to stimulate creative research and promote excellence.”
- Barack Obama, US President - 2008
Tedros-Adhanom-Ghebreyesus
“I look forward to the day when we will celebrate an African winner of the Prix Galien.“
- Tedros Adhanom Ghebreyesus, Director-General, WHO - 2018
john-major
“It is a pleasure to congratulate all those who promote the Prix Galien and pharmaceutical research: they play a vital role in the fight against disease throughout the world."
- John Major, UK Prime Minister - 1996